RESUMEN
INTRODUCTION: Cross-reactivity between shrimp and house dust mite (HDM) proteins has been widely documented. In tropical region, shrimp (5-15%) and mite sensitization (80-95%) is prevalent in allergic patients. However, the clinical relevance of shrimp sensitization in patients with allergic rhinitis (AR) has been poorly studied. The aim of this study was to determine the prevalence and the clinical relevance shrimp IgE sensitization in AR patients sensitized to Dermatophagoides pteronyssinus. METHODS: The study was conducted in Medellin (Colombia). A cross-sectional study in patients with AR sensitized to HDM was performed in 3 steps: (i) assessment of IgE sensitization frequency to shrimp Penaeus azteca, Litopenaeus vannamei, and tropomyosin homologous allergens rDer p 10, rPen a 1, and rLit v 1, (ii) evaluation of the clinical relevance of shrimp sensitization using oral challenge test (OCT) and (iii) identification of possible risk factors for positive-OCT results. Ethical committee approval was obtained. RESULTS: From 443 patients with AR, 86 (19.4%) were sensitized to shrimp and 23 of them (26.7%) had shrimp allergy diagnosis. Thirty-six of the patients sensitized to shrimp (41.2%) reported not previously consumed this food and eleven of them had a positive-OCT (30.5%). There was not statistically significant difference in total IgE or sIgE (D. pteronyssinus, P. azteca, L. vannamei, rPen a 1, and rLit v 1) between OCT groups (positive vs. negative results). Anti-Der p 10 IgE was associated with risk for a positive-OCT in different multivariable scenarios. DISCUSSION/CONCLUSION: Our results suggest that in patients with HDM-associated AR and shrimp IgE sensitization is necessary to evaluate the clinical relevance of shrimp IgE even if the patient has never consumed shrimp because of cross-reactivity. Anti-Der p 10 could be a possible biomarker of clinical relevance to shrimp sensitization and could reduce the need for OCTs.
Asunto(s)
Antígenos Dermatofagoides/inmunología , Proteínas de Artrópodos/inmunología , Hipersensibilidad a los Alimentos/inmunología , Inmunoglobulina E/sangre , Penaeidae/inmunología , Rinitis Alérgica/inmunología , Tropomiosina/inmunología , Adulto , Alérgenos/inmunología , Animales , Reacciones Cruzadas , Estudios Transversales , Femenino , Hipersensibilidad a los Alimentos/sangre , Humanos , Inmunoglobulina E/inmunología , Pruebas Inmunológicas , Masculino , Persona de Mediana Edad , Rinitis Alérgica/sangre , Método Simple Ciego , Adulto JovenRESUMEN
OBJECTIVE: To evaluate the risk of IgE sensitization and symptoms to shrimp in a population that has received AIT with polymerized mite extract. METHODS: Patients with allergic rhinitis sensitized to dust mites (Dermatophogides spp) with an indication for mite AIT were included. Those patients who had not yet received AIT or had received less than 6 doses were included as controls and those who had received more than 24 doses of AIT were included as cases. Sensitization to shrimp was assessed by skin prick test with complete shrimp extract and/or shrimp-specific IgE. RESULTS: A total of 68 patients were included; 47 cases and 21 controls. When calculating the odds ratio of sensitization according to time with immunotherapy we observed that there were no differences between the group of cases and controls (OR 0.76 95% CI 0.26 to 2.22 p 0.7 by MacNemar technique). Factors such as consumption or not of shrimp and frequency of consumption do not seem to be related to the outcome. CONCLUSION: In contrast to what was reported with aqueous extracts, we observed that AIT with polymerized extracts is not a risk factor for shrimp sensitization. It is necessary to reproduce these results with a larger sample size to explore other factors.
OBJETIVO: Evaluar el riesgo de sensibilización IgE y síntomas a camarón en una población que ha recibido AIT con extracto polimerizado para ácaros. MÉTODOS: Se incluyeron pacientes con rinitis alérgica sensibilizados a ácaros del polvo (Dermatophogides spp) con indicación de AIT para ácaros. Aquellos pacientes que no habían aún recibido AIT o llevaban menos de seis dosis, fueron incluidos como controles, y aquellos que llevaban más de 24 dosis de AIT, fueron incluidos como casos. Se evaluó la sensibilización a camarón mediante prueba cutánea con extracto completo de camarón y/o IgE específica a camarón. RESULTADOS: En total, 68 pacientes fueron incluidos; 47 casos y 21 controles. Al calcular el odds ratio de la sensibilización de acuerdo al tiempo con la inmunoterapia, observamos que no había diferencias entre el grupo de casos y controles (OR 0,76 95% IC 0,26 a 2,22 p 0,7 por técnica de MacNemar). Factores como el consumo o no de camarón y la frecuencia de consumo, no parecen estar relacionados con el desenlace. CONCLUSIÓN: A diferencia de lo reportado con extractos acuosos, observamos de AIT con extractos polimerizados para no es un factor de riesgo para la sensibilización a camarón. Es necesario reproducir estos resultados con un mayor tamaño de muestra que permita explorar otros factores.
Asunto(s)
Desensibilización Inmunológica , Penaeidae , Pyroglyphidae , Humanos , Animales , Masculino , Femenino , Pyroglyphidae/inmunología , Adulto , Penaeidae/inmunología , Adolescente , Adulto Joven , Niño , Persona de Mediana Edad , Polimerizacion , Rinitis Alérgica/terapia , Antígenos Dermatofagoides/inmunología , Inmunoglobulina E/inmunologíaRESUMEN
Background: Economic evaluation in health care is becoming increasingly important. Laparoscopic appendectomy (LAp) is one of the most frequent minimally invasive procedures in the pediatric population. The increased costs of this approach in any indication could be justified by proving its cost-utility in terms of health-related quality of life (HRQoL). We aim to perform a cost-utility analysis between open and LAp (open appendectomy [OAp] and LAp). Materials and Methods: We included the data of children operated for acute noncomplicated appendicitis, who agreed to answer a validated quality of life (QoL) questionnaire. Costs were calculated for each patient. We established a threshold for cost-effectiveness (λ) of 20,000 to 30,000 per quality adjusted life year (QALY) according to previous research. Results: A total of 53 patients were included. Overall mean costs in the OAp were 758.98 and in the LAp 1525.50. The incremental cost-effectiveness ratio was 18,000/QALY, under the threshold of cost-effectiveness, therefore favoring the laparoscopic approach as it improves HRQoL despite the costs. Conclusions: Economic evaluation studies in Pediatric Surgery are scarce and rarely measure outcomes in terms of QoL. This information is important in the decision-making process for institutions and health-care professionals. Our results encourage the use of laparoscopy in pediatric appendectomy to improve HRQoL in our patients.
Asunto(s)
Laparoscopía , Calidad de Vida , Apendicectomía , Niño , Análisis Costo-Beneficio , Humanos , Procedimientos Quirúrgicos Mínimamente InvasivosRESUMEN
Anaemia of chronic disease (ACD) is generated by the activation of the immune system by autoantigens, microbial molecules or tumour antigens resulting in the release of cytokines that cause an elevation of serum hepcidin, hypoferraemia, suppression of erythropoiesis, decrease in erythropoietin (EPO) and shortening of the half-life of red blood cells. Anaemia is usually normocytic and normochromic, which is the most prevalent after iron deficiency anaemia, and it is the most frequent in the elderly and in hospitalized patients. If the anaemia is severe, the patient's quality of life deteriorates, and it can have a negative impact on survival. Treatment is aimed at controlling the underlying disease and correcting anaemia. Sometimes intravenous iron and EPO have been used, but the therapeutic future is directed against hepcidin, which is the final target of anaemia.
Asunto(s)
Anemia , Eritropoyetina , Anciano , Anemia/diagnóstico , Anemia/etiología , Anemia/terapia , Enfermedad Crónica , Hepcidinas , Humanos , Hierro , Calidad de VidaRESUMEN
BACKGROUND: Many patients with chronic spontaneous urticaria (CSU) experience exacerbations after the administration of nonsteroidal anti-inflammatory drugs (NSAIDs), with clinical implications for the selection of therapeutic options for pain management. Case reports suggest that antihistamines could prevent these reactions. OBJECTIVE: To determine whether antihistamines can prevent NSAID-exacerbated reactions in patients with CSU. METHODS: Data on 121 patients with CSU and a history of NSAID exacerbations were evaluated. Two types of challenge with NSAIDs were performed using the NSAIDs reported in the medical record (a diagnostic challenge test without the use of antihistamines and a challenge test using antihistamines). The order in which the tests were performed in each patient was dependent on the treating physician. Patients with a positive first diagnostic challenge underwent a second challenge using H1-antihistamines (anti-H1), patients with a negative first challenge using anti-H1 underwent a second diagnostic challenge without the use of anti-H1, and patients with a negative first diagnostic challenge or a positive first challenge using anti-H1 did not undergo a second challenge. In some patients, additional challenges were performed with an alternative NSAID before performing the diagnostic challenge test or the challenge test using anti-H1. RESULTS: In the diagnostic challenge test, 96 patients tested positive. Seventy-two (75%) of these patients tolerated the NSAIDs involved in the reaction when they used antihistamines. CONCLUSIONS: NSAID restrictions create many inconveniences for patients with CSU. Clinical control of CSU with the use of antihistamines can prevent further exacerbations due to NSAID intake in many patients to help them avoid unnecessary restrictions.
Asunto(s)
Urticaria Crónica , Hipersensibilidad a las Drogas , Urticaria , Antiinflamatorios no Esteroideos/efectos adversos , Hipersensibilidad a las Drogas/diagnóstico , Antagonistas de los Receptores Histamínicos/uso terapéutico , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Humanos , Urticaria/diagnóstico , Urticaria/tratamiento farmacológicoRESUMEN
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder in which airflow is obstructed. Viral or bacterial upper respiratory tract infections (URTIs) may lead to exacerbations. Homeopathic medication administration to COPD patients during the influenza-exposure period may help to reduce the frequency of common URTIs. METHODS: This prospective, observational, multicenter study was carried out in Cantabria, Spain. Patients with COPD were divided into two groups: group 1 received conventional treatment + homeopathic medication (diluted and dynamized extract of duck liver and heart; Boiron) (OG); group 2 received conventional treatment only (CG). The primary endpoint was the number of URTIs between the 4-5 months follow up (mean 4.72 ± 0.96) from basal to last visit. Secondary endpoints included the duration of URTIs, number and duration of COPD exacerbations, use of COPD drugs, changes in quality of life (QoL), compliance, and adverse events (AEs). RESULTS: 219 patients were analyzed (OGâ¯=â¯109, CGâ¯=â¯110). There was a significant reduction in mean number of URTIs during the follow-up period in OG compared to CG (0.514⯱â¯0.722 vs. 1.037⯱â¯1.519, respectively; pâ¯=â¯0.014). Logistic regression analysis showed a 3.3-times higher probability of suffering ≥2 URTI episodes in CG (pâ¯=â¯0.003, nâ¯=â¯72). OG patients having ≥1 URTI also had a significant reduction in mean URTI duration per episode (3.57⯱â¯2.44 days OG vs. 5.22⯱â¯4.17 days CG; pâ¯=â¯0.012). There was no significant difference in mean number of exacerbations, mean duration of exacerbations, or QoL between OG and CG. There was a greater decrease in proportion of patients using corticosteroids for exacerbations between baseline and visit 2 in OG compared to CG (22.1% vs. 7.5% fewer respectively, pâ¯=â¯0.005). Exacerbator phenotype patients had a significant decrease in number of URTIs (0.54⯱â¯0.72 vs. 1.31⯱â¯1.81; pâ¯=â¯0.011), and fewer COPD exacerbations (0.9⯱â¯1.3 vs. 1.5⯱â¯1.7; pâ¯=â¯0.037) in OG vs. CG, respectively. CONCLUSIONS: Homeopathic medication use during the influenza-exposure period may have a beneficial impact at reducing URTIs' number and duration in COPD patients and at reducing the number of COPD exacerbations in patients with the exacerbator phenotype. Further studies are needed to confirm the effects observed in this study.
Asunto(s)
Corticoesteroides/uso terapéutico , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Infecciones del Sistema Respiratorio/prevención & control , Corticoesteroides/efectos adversos , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Femenino , Homeopatía , Humanos , Modelos Logísticos , Persona de Mediana Edad , Estudios Prospectivos , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Calidad de Vida , Infecciones del Sistema Respiratorio/epidemiología , España/epidemiología , Resultado del TratamientoRESUMEN
Large continental faults extend for thousands of kilometres to form boundaries between rigid tectonic blocks. These faults are associated with prominent topographic features and can produce large earthquakes. Here we show the first evidence of a major tectonic structure in its initial-stage, the Al-Idrissi Fault System (AIFS), in the Alboran Sea. Combining bathymetric and seismic reflection data, together with seismological analyses of the 2016 Mw 6.4 earthquake offshore Morocco - the largest event ever recorded in the area - we unveil a 3D geometry for the AIFS. We report evidence of left-lateral strike-slip displacement, characterise the fault segmentation and demonstrate that AIFS is the source of the 2016 events. The occurrence of the Mw 6.4 earthquake together with historical and instrumental events supports that the AIFS is currently growing through propagation and linkage of its segments. Thus, the AIFS provides a unique model of the inception and growth of a young plate boundary fault system.
RESUMEN
BACKGROUND: Much is known about the frequency of sensitization to Blomia tropicalis, Dermatophagoides pteronyssinus and Dermatophagoides farinae, although less is known about sensitization to other species and their possible interactions. OBJECTIVE: In patients with allergic manifestations, to evaluate the frequency of sensitization to 10 species of mites in a tropical area and their possible interactions. METHODS: Cross-sectional study. Sensitization was evaluated by skin tests. A generalized linear Poisson regression model with robust variance was used. Based on the sensitization probability reasons and social networking analysis, explorations of relationship for 10 mites were performed. RESULTS: 147 patients were included. The highest sensitization was found to mites' family Pyroglyphidae (> 70 %) and less frequently was the Glycyphagidae family (< 50 %). Sensitization to any mites significantly increased the likelihood of sensitization to others. Sensitization to Der f or Der p increased, more than 20 times the likelihood of sensitization to other mites of the Pyroglyphidae family and more than 10 times to mites from other families. Sensitization to mites from Glycyphagidae, Chortoglyphidae or Acaridae family also increased the risk of sensitization to other mites but less than 5 times. CONCLUSION: Sensitization to mites is frequent in tropical area. Pyroglyphidae sensitization is the main risk factor for polysensitization with other mites from Glycyphagidae, Chortoglyphidae or Acaridae. These results must be considered at diagnosis and treatment of allergy diseases.
Asunto(s)
Hipersensibilidad Inmediata/etiología , Ácaros/inmunología , Adolescente , Adulto , Anciano , Animales , Antígenos Dermatofagoides/efectos adversos , Antígenos Dermatofagoides/inmunología , Proteínas de Artrópodos/efectos adversos , Proteínas de Artrópodos/inmunología , Niño , Preescolar , Colombia , Estudios Transversales , Cisteína Endopeptidasas/efectos adversos , Cisteína Endopeptidasas/inmunología , Femenino , Humanos , Hipersensibilidad Inmediata/epidemiología , Masculino , Persona de Mediana Edad , Ácaros/clasificación , Factores de Riesgo , Serina Endopeptidasas/efectos adversos , Serina Endopeptidasas/inmunología , Pruebas Cutáneas , Especificidad de la Especie , Clima Tropical , Adulto JovenRESUMEN
Hepcidin is the main regulator of iron metabolism and a pathogenic factor in iron disorders. Hepcidin deficiency causes iron overload, whereas hepcidin excess causes or contributes to the development of iron-restricted anaemia in chronic inflammatory diseases. We know the mechanisms involved in the synthesis of hepcidin and, under physiological conditions, there is a balance between activating signals and inhibitory signals that regulate its synthesis. The former include those related to plasmatic iron level and also those related to chronic inflammatory diseases. The most important inhibitory signals are related to active erythropoiesis and to matriptase-2. Knowing how hepcidin is synthesised has helped design new pharmacological treatments whose main target is the hepcidin. In the near future, there will be effective treatments aimed at correcting the defect of many of these iron metabolism disorders.
Asunto(s)
Hepcidinas/metabolismo , Trastornos del Metabolismo del Hierro/metabolismo , Hierro/metabolismo , Biomarcadores/metabolismo , Proteínas de Transporte de Catión/metabolismo , Homeostasis , Humanos , Trastornos del Metabolismo del Hierro/diagnóstico , Trastornos del Metabolismo del Hierro/etiología , Trastornos del Metabolismo del Hierro/terapiaRESUMEN
Allergies comprise a set of highly prevalent diseases. When allergic processes are not controlled, they can endanger patients' health and lives, and have an important economic and social impact. The aim of this paper is to present a practical consensus of the scientific evidence on the use of immunotherapy in allergic diseases. A collaborative review made by various institutes and universities in Colombia was carried out upon request of the Asociación Colombiana de Alergia, Asma e Imunología, led by general practitioners, allergists, immunologists, internists and paediatricians with experience in the field of allergies. As a result, based on current national and international scientific evidence, we describe in detail what immunotherapy is about, its indications, contraindications and its economic and health benefits. Conclusions show immunotherapy as a clinically effective and safe treatment, which can substantially reduce the cost of the overall treatment of allergic patients.
Asunto(s)
Alérgenos , Desensibilización Inmunológica , Colombia , Consenso , Humanos , HipersensibilidadRESUMEN
INTRODUCTION: Among allergic patients, pet avoidance is commonly recommended. It is difficult for patients to accomplish this because of their emotional attachment to the pets, and its effectiveness is controversial. OBJECTIVE: To explore the applicability and effectiveness of pet avoidance measures among sensitized patients. MATERIALS AND METHODS: We evaluated 288 patients with asthma, rhinitis, conjunctivitis and/or dermatitis using skin prick test to measure their sensitization to cats, dogs and other animals to which they were exposed. Exposure to animals was evaluated in each patient (pets at home, frequent indirect exposure or no exposure). In those patients sensitized to animals some avoidance measures, such as removing pets from home and preventing indirect exposure, were recommended. On the following two appointments, we evaluated patients' fulfillment of these recommendations. RESULTS: Sensitization to cats, dogs and birds was high (9%, 48%, 14%, respectively), as well as direct and indirect exposure (30%, 46%, 24%, respectively). Most patients denied contact with other animals (horses, hamsters, rabbits or cows), and sensitization to them was low. During the follow-up of patients sensitized to their pets at home (n=50), most of them refused to remove them from their house due to emotional attachment, and only two followed this recommendation. CONCLUSIONS: High exposure to animals could explain the frequency of sensitization to pets in this population. However, emotional attachment and prevalent indirect exposure to animals among sensitized patients make avoidance recommendations impractical or impossible to achieve.
Asunto(s)
Hipersensibilidad/prevención & control , Cooperación del Paciente , Mascotas , Adolescente , Adulto , Anciano , Alérgenos/inmunología , Animales , Asma/etiología , Asma/prevención & control , Aves/inmunología , Gatos/inmunología , Niño , Preescolar , Dermatitis Atópica/etiología , Dermatitis Atópica/prevención & control , Perros/inmunología , Emociones , Exposición a Riesgos Ambientales , Femenino , Humanos , Hipersensibilidad/etiología , Lactante , Masculino , Persona de Mediana Edad , Mascotas/inmunología , Estudios Prospectivos , Rinitis/etiología , Rinitis/prevención & control , Pruebas Cutáneas , Especificidad de la Especie , Adulto JovenRESUMEN
BACKGROUND AND OBJECTIVES: Cathepsin D is an aspartyl proteinase involved in tumoral invasion. The aim of this work was to study cathepsin D cytosolic levels in squamous carcinomas of the lung and their correlation with several clinical and biological parameters. PATIENTS AND METHOD: The study group included 95 squamous lung carcinomas and 38 normal tissue samples from the same patients. Cathepsin D cytosolic concentrations were determined using an immunoradiometric assay (CIS BioInternational. France). EGFR, erbB2 protein, CD44s, CD44v5 and CD44v6 levels at cell surfaces were determined. The clinical stage, histological grade, ploidy and S-phase cellular fraction (SP) were also considered as variables of the study. RESULTS: Cathepsin D cytosolic levels oscillated between 7.7 and 576 (median: 38.8) pmol/mg protein and were lower (p = 0.001) than those observed in 38 normal lung samples from the same patients. When tumors were classified according to different clinical and biological parameters, we noticed that cathepsin D levels were higher in carcinomas with lower proliferation rates and no nodal involvement, reaching statistical significance in both cases. Moreover, when lung carcinomas were classified according to cathepsin D concentrations, tumors with higher cathepsin D concentrations had lower EGFR levels (p = 0.011) and small global SP values (p = 0.025) and DNA index (p = 0.023). Likewise, they were found to be CD44s positive more frequently (p = 0.001) and SP positive less frequently (p = 0.022). CONCLUSIONS: These results lead us to suggest the following: a) in squamous carcinomas of the lung, cathepsin D cytosolic levels are lower than those observed in normal lung samples from the same patients, and b) in this subtype of lung carcinomas, high cathepsin D levels are associated with tumors without nodal involvement, with low proliferation rates, lower EGFR levels, and a reduced positivity for CD44s, pointing to a possible role of this proteinase as a parameter of good outcome.
Asunto(s)
Carcinoma de Células Escamosas/enzimología , Catepsina D/metabolismo , Neoplasias Pulmonares/enzimología , Adulto , Anciano , Carcinoma de Células Escamosas/patología , Citosol/enzimología , Receptores ErbB/metabolismo , Glicoproteínas/metabolismo , Humanos , Receptores de Hialuranos/metabolismo , Ensayo Inmunorradiométrico , Neoplasias Pulmonares/patología , Persona de Mediana Edad , Receptor ErbB-2/metabolismoRESUMEN
BACKGROUND: Pet avoidance is commonly recommended to allergic patients, even if an IgE-mediated sensitization has not been demonstrated. This management is difficult to accomplish by patients with emotional attachment to their pets and the effectiveness is controversial. OBJECTIVE: To assess the sensitization to different animals among patients with asthma, rhinitis, conjunctivitis and/or dermatitis. To assess the sensitization to different animals among patients with asthma, rhinitis, conjunctivitis and/or dermatitis. PATIENTS AND METHOD: A retrospective study was performed with 300 previously reported patients with asthma, rhinitis, conjunctivitis and/or dermatitis; we organized two groups: Group 1 included patients who were tested skin sensitization to both dog and cat. Group 2 was comprised of all patients with skin testing droppings or feathers of birds (canary, parrot, pigeon or hen). RESULTS: Sensitization to cat and especially to dog was high (7% and 47%, respectively). The co-sensitization to dog was high among patients sensitized to cat (85%). Sensitization to other epithelia (horse, hamster, rabbit, cow) was low. About birds, there was a greater sensitization to proteins contained in the feces than in the feathers, pigeon sensitization was the most frequent. We observed no differences in the pattern of sensitization among patients according to age, gender or allergic symptoms. CONCLUSIONS: The frequency of co-sensitization with cat and dog was high, which may be explained by shared proteins between the two species as lipocalins. About birds, the proteins in pigeon droppings were the main cause of sensitization; however, it does not seem to share cross-reactivity with other birds and the frequency was relatively low compared with epithelia allergens.
ANTECEDENTES: comúnmente se recomienda a los pacientes alérgicos evitar las mascotas, aun si no se ha demostrado sensibilización IgE mediada. Esta medida, sin una sensibilización demostrada, no es necesaria; además, es difícil de cumplir por parte de los pacientes con apego afectivo a sus mascotas y su eficacia es controvertida. OBJETIVO: evaluar la sensibilización a diferentes animales en pacientes con asma, rinitis, conjuntivitis, dermatitis o todas. PACIENTES Y MÉTODO: estudio retrospectivo efectuado a partir de una población previamente reportada de 300 pacientes con asma, rinitis, conjuntivitis, dermatitis o con combinaciones de éstas; se formaron dos grupos: el grupo 1 estuvo conformado por los pacientes a quienes se realizaron pruebas cutáneas de sensibilización a gato y a perro. El grupo 2 estuvo conformado por todos los pacientes con pruebas cutáneas para excremento o plumas de aves (canario, perico, paloma o gallina). RESULTADOS: la sensibilización a gato y especialmente a perro fue alta (7 y 47%, respectivamente). La cosensibilización a perro fue alta entre los pacientes sensibilizados a gato (85%). La sensibilización a otros epitelios (caballo, hámster, conejo, vaca) fue baja. Con respecto a las aves, se observó mayor sensibilización a las proteínas contenidas en los excrementos, la sensibilización a paloma fue la más frecuente. No observamos diferencias en el patrón de sensibilización entre los pacientes de acuerdo con la edad, género o los síntomas alérgicos. CONCLUSIONES: la frecuencia de cosensibilización a gato y a perro fue alta, lo que puede explicarse por proteínas compartidas entre las dos especies, como las lipocalinas. Con respecto a las aves, las proteínas contenidas en el excremento de paloma fueron la principal causa de sensibilización; sin embargo, no parece compartir reactividad cruzada con otras aves y la frecuencia fue relativamente baja en comparación con los epitelios.
Asunto(s)
Hipersensibilidad/epidemiología , Mascotas , Adolescente , Adulto , Anciano , Animales , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Medicina Tropical , Adulto JovenRESUMEN
Las alergias constituyen un conjunto de enfermedades de gran prevalencia. Cuando los procesos alérgicos no se controlan, pueden poner en peligro la salud e, incluso, la vida de los pacientes y, además, su efecto económico y social es considerable. El objetivo de esta revisión es presentar un consenso práctico de la información científica disponible sobre el empleo de la inmunoterapia en las enfermedades alérgicas con la colaboración de varios institutos y universidades de Colombia, por solicitud de la Asociación Colombiana de Alergia, Asma e Inmunología. La revisión incluyó aspectos prácticos presentados desde el punto de vista de médicos generales, alergólogos, inmunólogos, internistas y pediatras con experiencia en el campo de las alergias. Con base en la evidencia científica actual a nivel nacional e internacional, se describió de forma detallada en qué consiste la inmunoterapia, sus indicaciones, contraindicaciones y sus beneficios para la salud, así como en el ámbito socioeconómico. Se concluyó que la inmunoterapia es efectiva y segura, y que, además, puede reducir sustancialmente el costo del tratamiento global de los pacientes alérgicos.
Allergies comprise a set of highly prevalent diseases. When allergic processes are not controlled, they can endanger patients´ health and lives, and have an important economic and social impact. The aim of this paper is to present a practical consensus of the scientific evidence on the use of immunotherapy in allergic diseases. A collaborative review made by various institutes and universities in Colombia was carried out upon request of the Asociación Colombiana de Alergia, Asma e Imunología , led by general practitioners, allergists, immunologists, internists and paediatricians with experience in the field of allergies. As a result, based on current national and international scientific evidence, we describe in detail what immunotherapy is about, its indications, contraindications and its economic and health benefits. Conclusions show immunotherapy as a clinically effective and safe treatment, which can substantially reduce the cost of the overall treatment of allergic patients.
Asunto(s)
Alérgenos , Anafilaxia , Asma , Conjuntivitis , Consenso , Dermatitis , Himenópteros , Inmunoterapia , RinitisRESUMEN
Introduction: Among allergic patients, pet avoidance is commonly recommended. It is difficult for patients to accomplish this because of their emotional attachment to the pets, and its effectiveness is controversial. Objective: To explore the applicability and effectiveness of pet avoidance measures among sensitized patients. Materials and methods: We evaluated 288 patients with asthma, rhinitis, conjunctivitis and/or dermatitis using skin prick test to measure their sensitization to cats, dogs and other animals to which they were exposed. Exposure to animals was evaluated in each patient (pets at home, frequent indirect exposure or no exposure). In those patients sensitized to animals some avoidance measures, such as removing pets from home and preventing indirect exposure, were recommended. On the following two appointments, we evaluated patients' fulfillment of these recommendations. Results: Sensitization to cats, dogs and birds was high (9%, 48%, 14%, respectively), as well as direct and indirect exposure (30%, 46%, 24%, respectively). Most patients denied contact with other animals (horses, hamsters, rabbits or cows), and sensitization to them was low. During the follow-up of patients sensitized to their pets at home (n=50), most of them refused to remove them from their house due to emotional attachment, and only two followed this recommendation. Conclusions: High exposure to animals could explain the frequency of sensitization to pets in this population. However, emotional attachment and prevalent indirect exposure to animals among sensitized patients make avoidance recommendations impractical or impossible to achieve.
Introducción. Entre los pacientes alérgicos se recomienda comúnmente la evitación de mascotas; sin embargo, es difícil que los pacientes cumplan con esta recomendación debido al apego emocional y, además, su efecto clínico no es claro. Objetivo. Explorar la aplicabilidad de las medidas de evitación entre pacientes sensibilizados a mascotas . Materiales y métodos. En 284 pacientes con asma, rinitis, conjuntivitis y dermatitis, se evaluó la sensibilización a gatos, perros y otros animales mediante pruebas de punción epidérmica. Se evaluó, igualmente, el nivel de exposición a animales (mascotas en la casa y exposición indirecta frecuente). A aquellos pacientes sensibilizados a los animales, se les recomendaron medidas de evitación como retirar la mascota de la casa y evitar la exposición indirecta. En las dos citas médicas siguientes se evaluó el cumplimiento de estas recomendaciones. Resultados. La sensibilización a gatos, perros y aves fue alta (9, 48, y 14 %, respectivamente), al igual que la exposición directa o indirecta a estos animales (30, 46, 24 %, respectivamente). La mayoría de los pacientes negó el contacto frecuente con otros animales (caballos, hámsteres, conejos, vacas) y la sensibilización a estos fue baja. La mayoría de los pacientes sensibilizados a su propia mascota (n= 50) se rehusó a retirar la mascota de la casa y solo dos de ellos siguieron la recomendación de hacerlo. Conclusiones. La exposición frecuente a los animales podría explicar la gran frecuencia de sensibilización a las mascotas en esta población. Sin embargo, el apego emocional y la exposición indirecta frecuente, hacen que las recomendaciones de evitación sean imprácticas o casi imposibles de lograr.